JUN and leukemia: The activation of JNK and increased expression of c-Jun have been associated with the apoptotic death of human leukemia cells treated with paclitaxel (PTX) and epidermoid carcinoma cells treated with PTX and vinblastine (VBL) [109,110,111,112].